中华麻醉学杂志
中華痳醉學雜誌
중화마취학잡지
Chinese Journal of Anesthesiology
2015年
9期
1041-1043
,共3页
李艳超%邓恢伟%毛鑫诚%张国光%付卫东%潘道波
李豔超%鄧恢偉%毛鑫誠%張國光%付衛東%潘道波
리염초%산회위%모흠성%장국광%부위동%반도파
缺血预处理%下肢%心肺转流术%心脏瓣膜假体植入%肝损伤
缺血預處理%下肢%心肺轉流術%心髒瓣膜假體植入%肝損傷
결혈예처리%하지%심폐전류술%심장판막가체식입%간손상
Ischemic preconditioning%Lower extremity%Cardiopulmonary bypass%Heart valve prosthesis implantation%Liver injury
目的 评价肢体缺血预处理对CPB下心脏瓣膜置换术患者肝损伤的影响.方法 择期CPB下行心脏瓣膜置换术患者60例,性别不限,体重44 ~ 72 kg,ASA分级Ⅱ或Ⅲ级,心功能Ⅱ或Ⅲ级,左心室射血分数≥40%,采用随机数字表法,将其分为2组(n=30):对照组(C组)和肢体缺血预处理组(E组).E组于麻醉诱导后将止血带置于患者右下肢,充气到300 mmHg,实施3个周期的缺血5 min-再灌注5 min.分别于麻醉诱导前(T0)、术后2 h(T1)、12 h(T2)、24 h(T3)、72 h(T4)和7 d(T5)时,采集右侧颈内静脉血样,检测血清ALT和AST的活性;于T0-4时采用RT-PCR法测定血清微小RNA122(miR-122)的表达水平.结果 与T0时比较,2组T2-4时血清ALT和AST的活性升高,T1-3时miR-122表达上调(P<0.05);与C组比较,T2-4时E组血清ALT和AST的活性降低,T1-3时miR-122表达下调(P<0.05).结论 肢体缺血预处理可减轻CPB下心脏瓣膜置换术患者的肝损伤.
目的 評價肢體缺血預處理對CPB下心髒瓣膜置換術患者肝損傷的影響.方法 擇期CPB下行心髒瓣膜置換術患者60例,性彆不限,體重44 ~ 72 kg,ASA分級Ⅱ或Ⅲ級,心功能Ⅱ或Ⅲ級,左心室射血分數≥40%,採用隨機數字錶法,將其分為2組(n=30):對照組(C組)和肢體缺血預處理組(E組).E組于痳醉誘導後將止血帶置于患者右下肢,充氣到300 mmHg,實施3箇週期的缺血5 min-再灌註5 min.分彆于痳醉誘導前(T0)、術後2 h(T1)、12 h(T2)、24 h(T3)、72 h(T4)和7 d(T5)時,採集右側頸內靜脈血樣,檢測血清ALT和AST的活性;于T0-4時採用RT-PCR法測定血清微小RNA122(miR-122)的錶達水平.結果 與T0時比較,2組T2-4時血清ALT和AST的活性升高,T1-3時miR-122錶達上調(P<0.05);與C組比較,T2-4時E組血清ALT和AST的活性降低,T1-3時miR-122錶達下調(P<0.05).結論 肢體缺血預處理可減輕CPB下心髒瓣膜置換術患者的肝損傷.
목적 평개지체결혈예처리대CPB하심장판막치환술환자간손상적영향.방법 택기CPB하행심장판막치환술환자60례,성별불한,체중44 ~ 72 kg,ASA분급Ⅱ혹Ⅲ급,심공능Ⅱ혹Ⅲ급,좌심실사혈분수≥40%,채용수궤수자표법,장기분위2조(n=30):대조조(C조)화지체결혈예처리조(E조).E조우마취유도후장지혈대치우환자우하지,충기도300 mmHg,실시3개주기적결혈5 min-재관주5 min.분별우마취유도전(T0)、술후2 h(T1)、12 h(T2)、24 h(T3)、72 h(T4)화7 d(T5)시,채집우측경내정맥혈양,검측혈청ALT화AST적활성;우T0-4시채용RT-PCR법측정혈청미소RNA122(miR-122)적표체수평.결과 여T0시비교,2조T2-4시혈청ALT화AST적활성승고,T1-3시miR-122표체상조(P<0.05);여C조비교,T2-4시E조혈청ALT화AST적활성강저,T1-3시miR-122표체하조(P<0.05).결론 지체결혈예처리가감경CPB하심장판막치환술환자적간손상.
Objective To evaluate the effects of extremity ischemic preconditioning on liver injury after cardiac valve replacement with cardiopulmonary bypass (CPB).Methods Sixty ASA physical status Ⅱ or Ⅲ patients (NYHA Ⅱ or Ⅲ), weighing 44-72 kg, with ejection fraction≥40%, schedule for elective cardiac valve replacement with CPB, were randomly divided into 2 groups (n =30 each) using a random number table: control group (group C) and extremity ischemic preconditioning group (group E).Immediately after anesthesia induction, an auto-inflatable cuff was placed under the right lower extremity, and was inflated to 300 mmHg to induce ischemia (oxygen saturation at the finger tip undetected or foot pulse untouched on the operated side) which was preceded by 3 cycles of 5 min ischemia-5 min reperfusion in group E.Before anesthesia induction (T0) , and at 2, 12, 24, and 72 h, and 7 days after operation (T1-5) , blood samples were taken from the right internal jugular vein for determination of serum alanine aminotransferase (ALT) and aspartate aminotransferase (AST) activities.The expression of serum miR-122 was detected at T0-4 by real-time reverse transcriptase polymerase chain reaction.Results Compared with the value at T0, the serum ALT and AST activities were significantly increased at T2-4, and the expression of miR-122 was up-regulated at T1-3 in the two groups (P<0.05).Compared with group C, the serum ALT and AST activities were significantly decreased at T2-4, and the expression of miR-122 was down-regulated at T1-3in group E (P<0.05).Conclusion Extremity ischemic preconditioning can mitigate liver injury after cardiac valve replacement with CPB.